Rchr
J-GLOBAL ID：201901020702041615
Update date: Nov. 17, 2024
Hayashi Yasuhide
ハヤシ ヤスヒデ | Hayashi Yasuhide
Affiliation and department：
Job title：
resercher
Research field (1)：
Hematology and oncology
Research keywords (4)：
Oncology
, Hematology
, pediatrics
, cytogenetics
Papers (216)：
-
Masahiro Yoshitomi, Shin-Ichi Tsujimoto, Junji Ikeda, Tomoko Kawai, Kentaro Ohki, Yusuke Hara, Genki Yamato, Reo Tanoshima, Daisuke Tomizawa, Akira Shimada, et al. High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial. Pediatric blood & cancer. 2024. e31151
-
Shinju Iyoda, Kenichi Yoshida, Kota Shoji, Nana Ito, Miu Tanaka, Yasuhito Nannya, Genki Yamato, Shinichi Tsujimoto, Norio Shiba, Yasuhide Hayashi, et al. KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia. Leukemia. 2024. 38. 7. 1609-1612
-
Genki Yamato, Yusuke Tsumura, Hideki Muramatsu, Akira Shimada, Takahiro Imaizumi, Hiroyuki Tsukagoshi, Taeko Kaburagi, Norio Shiba, Yoshiyuki Yamada, Takao Deguchi, et al. Cytokine profiling in 128 patients with transient abnormal myelopoiesis: a report from the JPLSG TAM-10 trial. Blood advances. 2024
-
Yu Tao, Li Wei, Norio Shiba, Daisuke Tomizawa, Yasuhide Hayashi, Seishi Ogawa, Li Chen, Hua You. Development and validation of a promising 5-gene prognostic model for pediatric acute myeloid leukemia. Molecular biomedicine. 2024. 5. 1. 1-1
-
Takahiro Aoki, Norio Shiba, Shinichi Tsujimoto, Genki Yamato, Yusuke Hara, Shota Kato, Kenichi Yoshida, Seishi Ogawa, Yasuhide Hayashi, Shotaro Iwamoto, et al. High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core-binding factor. Pediatric blood & cancer. 2023. e30803
ｍore...
MISC (293)：
-
Genki Yamato, Tomoko Kawai, Norio Shiba, Yusuke Hara, Kentaro Ohki, Taeko Kaburagi, Etsuko Ishikita, Hirohide Kawasaki, Kenichi Yoshida, Yuichi Shiraishi, et al. Prognosis of Pediatric Acute Myeloid Leukemia with KMT2A-MLLT3 According to DNA Methylation Patterns: Jccg JPLSG AML-05 Study. BLOOD. 2022. 140. 9134-9135
-
Genki Yamato, Hideki Muramatsu, Tomoyuki Watanabe, Takao Deguchi, Shotaro Iwamoto, Daisuke Hasegawa, Kiminori Terui, Takahiro Ueda, Tomoko Yokosuka, Shiro Tanaka, et al. Predictive Factors of Leukemia in Patients With Transient Abnormal Myelopoiesis: JCCG JPLSG TAM-10 Study. PEDIATRIC BLOOD & CANCER. 2019. 66. S36-S36
-
Genki Yamato, Hideki Muramatsu, Tomoyuki Watanabe, Takao Deguchi, Shotaro Iwamoto, Daisuke Hasegawa, Kiminori Terui, Takahiro Ueda, Tomoko Yokosuka, Tsutomu Toki, et al. Predictive Factors of the Development of Leukemia in Patients with Transient Abnormal Myelopoiesis and Down Syndrome: The Jccg Study JPLSG TAM-10. BLOOD. 2019. 134
-
Koji Sasaki, Yuri Uchiyama, Junji Ikeda, Masahiro Yoshitomi, Yuko Shimosato-Wada, Mayu Tokumasu, Hidemasa Matsuo, Kenichi Yoshida, Kentaro Oki, Genki Yamato, et al. The Detection of Minor Clones with Somatic KIT D816V Mutations Using Droplet Digital PCR in Pediatric De Novo AML: AML-05 Trial from the Japanese Pediatric Leukemia/Lymphoma Study Group. BLOOD. 2019. 134
-
Ikeda Junji, Shiba Norio, Iizuka Atsuhiro, Yoshitomi Masahiro, Sasaki Koji, Takeuchi Masanobu, Kaburagi Taeko, Yamato Genki, Hara Yusuke, Hayashi Yasuhide, et al. ATAC-seqを用いた小児急性骨髄性白血病におけるオープンクロマチン領域の解析(Assay for transposase-accessible chromatin with sequencing(ATAC-seq) for analysis of open chromatin regions in pediatric acute myeloid leukemia). 日本小児血液・がん学会雑誌. 2019. 56. 4. 191-191
ｍore...
Education (1)：
- 1974 - 現在 University of Tokyo Medicine
Professional career (1)：
Return to Previous Page
